These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
111 related articles for article (PubMed ID: 20617400)
1. 1H, 13C and 15N resonance assignments of the human mesencephalic astrocyte-derived neurotrophic factor. Hellman M; Peränen J; Saarma M; Permi P Biomol NMR Assign; 2010 Oct; 4(2):215-7. PubMed ID: 20617400 [TBL] [Abstract][Full Text] [Related]
2. Therapeutic potential of the endoplasmic reticulum located and secreted CDNF/MANF family of neurotrophic factors in Parkinson's disease. Voutilainen MH; Arumäe U; Airavaara M; Saarma M FEBS Lett; 2015 Dec; 589(24 Pt A):3739-48. PubMed ID: 26450777 [TBL] [Abstract][Full Text] [Related]
3. Novel CDNF/MANF family of neurotrophic factors. Lindholm P; Saarma M Dev Neurobiol; 2010 Apr; 70(5):360-71. PubMed ID: 20186704 [TBL] [Abstract][Full Text] [Related]
4. Unconventional neurotrophic factors CDNF and MANF: Structure, physiological functions and therapeutic potential. Lindahl M; Saarma M; Lindholm P Neurobiol Dis; 2017 Jan; 97(Pt B):90-102. PubMed ID: 27425895 [TBL] [Abstract][Full Text] [Related]
5. Novel neurotrophic factor CDNF protects and rescues midbrain dopamine neurons in vivo. Lindholm P; Voutilainen MH; Laurén J; Peränen J; Leppänen VM; Andressoo JO; Lindahl M; Janhunen S; Kalkkinen N; Timmusk T; Tuominen RK; Saarma M Nature; 2007 Jul; 448(7149):73-7. PubMed ID: 17611540 [TBL] [Abstract][Full Text] [Related]
6. Chronic infusion of CDNF prevents 6-OHDA-induced deficits in a rat model of Parkinson's disease. Voutilainen MH; Bäck S; Peränen J; Lindholm P; Raasmaja A; Männistö PT; Saarma M; Tuominen RK Exp Neurol; 2011 Mar; 228(1):99-108. PubMed ID: 21185834 [TBL] [Abstract][Full Text] [Related]
7. Mesencephalic astrocyte-derived neurotrophic factor and cerebral dopamine neurotrophic factor: New endoplasmic reticulum stress response proteins. Liu H; Tang X; Gong L Eur J Pharmacol; 2015 Mar; 750():118-22. PubMed ID: 25637781 [TBL] [Abstract][Full Text] [Related]
8. (1)H-, (13)C- and (15)N-NMR assignment of the N-terminal domain of human cerebral dopamine neurotrophic factor (CDNF). Latgé C; Cabral KM; Almeida MS; Foguel D Biomol NMR Assign; 2013 Apr; 7(1):101-3. PubMed ID: 22528768 [TBL] [Abstract][Full Text] [Related]
9. Mesencephalic Astrocyte-Derived Neurotrophic Factor (MANF) Elevates Stimulus-Evoked Release of Dopamine in Freely-Moving Rats. Renko JM; Bäck S; Voutilainen MH; Piepponen TP; Reenilä I; Saarma M; Tuominen RK Mol Neurobiol; 2018 Aug; 55(8):6755-6768. PubMed ID: 29349573 [TBL] [Abstract][Full Text] [Related]
11. MANF: a new mesencephalic, astrocyte-derived neurotrophic factor with selectivity for dopaminergic neurons. Petrova P; Raibekas A; Pevsner J; Vigo N; Anafi M; Moore MK; Peaire AE; Shridhar V; Smith DI; Kelly J; Durocher Y; Commissiong JW J Mol Neurosci; 2003 Apr; 20(2):173-88. PubMed ID: 12794311 [TBL] [Abstract][Full Text] [Related]
12. The structure of the conserved neurotrophic factors MANF and CDNF explains why they are bifunctional. Parkash V; Lindholm P; Peränen J; Kalkkinen N; Oksanen E; Saarma M; Leppänen VM; Goldman A Protein Eng Des Sel; 2009 Apr; 22(4):233-41. PubMed ID: 19258449 [TBL] [Abstract][Full Text] [Related]
13. Cerebral dopamine neurotrophic factor protects and repairs dopamine neurons by novel mechanism. Lindholm P; Saarma M Mol Psychiatry; 2022 Mar; 27(3):1310-1321. PubMed ID: 34907395 [TBL] [Abstract][Full Text] [Related]
14. CDNF Protein Therapy in Parkinson's Disease. Huttunen HJ; Saarma M Cell Transplant; 2019 Apr; 28(4):349-366. PubMed ID: 30947516 [TBL] [Abstract][Full Text] [Related]
15. Cerebral dopamine neurotrophic factor reduces α-synuclein aggregation and propagation and alleviates behavioral alterations in vivo. Albert K; Raymundo DP; Panhelainen A; Eesmaa A; Shvachiy L; Araújo GR; Chmielarz P; Yan X; Singh A; Cordeiro Y; Palhano FL; Foguel D; Luk KC; Domanskyi A; Voutilainen MH; Huttunen HJ; Outeiro TF; Saarma M; Almeida MS; Airavaara M Mol Ther; 2021 Sep; 29(9):2821-2840. PubMed ID: 33940158 [TBL] [Abstract][Full Text] [Related]
16. CDNF and MANF in the brain dopamine system and their potential as treatment for Parkinson's disease. Pakarinen E; Lindholm P Front Psychiatry; 2023; 14():1188697. PubMed ID: 37555005 [TBL] [Abstract][Full Text] [Related]
17. The Solution Structure and Dynamics of Full-length Human Cerebral Dopamine Neurotrophic Factor and Its Neuroprotective Role against α-Synuclein Oligomers. Latge C; Cabral KM; de Oliveira GA; Raymundo DP; Freitas JA; Johanson L; Romão LF; Palhano FL; Herrmann T; Almeida MS; Foguel D J Biol Chem; 2015 Aug; 290(33):20527-40. PubMed ID: 26149686 [TBL] [Abstract][Full Text] [Related]
18. Neurotrophic factors hold promise for the future of Parkinson's disease treatment: is there a light at the end of the tunnel? Nasrolahi A; Mahmoudi J; Akbarzadeh A; Karimipour M; Sadigh-Eteghad S; Salehi R; Farhoudi M Rev Neurosci; 2018 Jul; 29(5):475-489. PubMed ID: 29305570 [TBL] [Abstract][Full Text] [Related]
19. 1H, 13C and 15N chemical shift assignments of Ninjurin1 Extracellular N-terminal Domain. Lee IG; Jang SB; Kim JH; Lee KY; Lee KY; Cheong HK; Lee BJ Biomol NMR Assign; 2013 Oct; 7(2):159-62. PubMed ID: 22696136 [TBL] [Abstract][Full Text] [Related]
20. Mesencephalic astrocyte-derived neurotrophic factor (MANF) has a unique mechanism to rescue apoptotic neurons. Hellman M; Arumäe U; Yu LY; Lindholm P; Peränen J; Saarma M; Permi P J Biol Chem; 2011 Jan; 286(4):2675-80. PubMed ID: 21047780 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]